Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Journal of the National Cancer Institute|October 15, 2016
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast CancerRico D Bense, Christos Sotiriou, Martine J Piccart-Gebhart, et al.International Journal of Molecular Sciences|September 10, 2021
Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular EndoscopyXiaojuan Zhao, Qingfeng Huang, Marjory Koller, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Theranostics Using Antibodies and Antibody-Related TherapeuticsKirsten L Moek, Danique Giesen, Iris C Kok, et al.Oncogene|September 5, 2018
TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cellsStephanie E van Gijn, Elles Wierenga, Nathalie van den Tempel, et al.Oral Oncology|February 29, 2024
Identification of new head and neck squamous cell carcinoma molecular imaging targetsJeroen E van Schaik, Bert van der Vegt, Lorian Slagter-Menkema, et al.Plos One|March 1, 2018
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approachMathilde R W de Jong, Lydia Visser, Gerwin Huls, et al.NPJ Breast Cancer|September 23, 2020
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancerSergi Guerrero Llobet, Bert van der Vegt, Evelien Jongeneel, et al.Journal for Immunotherapy of Cancer|March 18, 2025
Cyclin E1 overexpression triggers interferon signaling and is associated with antitumor immunity in breast cancerShibo Yu, Chantal Stappenbelt, Mengting Chen, et al.Elife|May 13, 2025
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancerArkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, et al.Cancer Metastasis Reviews|May 6, 2020
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapyPieter A Boonstra, Thijs T Wind, Michel van Kruchten, et al.Pageof 8